Transphorm, Inc. (TGAN)

Transphorm Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	7.95	16.03	33.94	14.69	2.88	3.07
Cash & Cash Equivalents	7.95	16.03	33.94	14.69	2.88	3.07
Cash Growth	-66.38%	-52.77%	130.94%	411.10%	-6.32%	-
Receivables	1.72	4.4	2.56	0.84	0.71	0.28
Inventory	10.01	8.41	6.33	1.63	0.99	0.85
Other Current Assets	1.28	1.86	1.97	1.06	0.78	0.62
Total Current Assets	20.95	30.69	44.79	18.23	5.36	4.83
Property, Plant & Equipment	9.99	10.92	1.65	1.32	1.77	2.13
Long-Term Investments	0	0.72	0.14	0	0	0
Goodwill and Intangibles	1.12	1.4	1.8	2.39	2.64	3.26
Other Long-Term Assets	0.6	0.73	0.26	0.29	0.5	0.28
Total Long-Term Assets	11.71	13.76	3.85	4	4.91	5.67
Total Assets	32.66	44.45	48.65	22.23	10.26	10.5
Accounts Payable	9.31	7.9	3.59	3.18	2.38	1.35
Deferred Revenue	0.01	0	0.35	0.67	0	3
Current Debt	0.37	12.4	0	20.15	15.46	10.35
Other Current Liabilities	2.73	1.64	1.35	2.68	2.85	1.83
Total Current Liabilities	12.41	21.94	5.29	26.69	20.69	16.53
Long-Term Debt	2	2.67	12	15.39	26.17	15.85
Other Long-Term Liabilities	0	0.23	0	0	0	0
Total Long-Term Liabilities	2	2.9	12	15.39	26.17	15.85
Total Liabilities	14.41	24.84	17.29	42.08	46.86	32.38
Total Debt	2.37	15.07	12	35.55	41.63	26.2
Debt Growth	-84.41%	25.62%	-66.24%	-14.61%	58.89%	-
Retained Earnings	-242.15	-209.24	-178.64	-161.82	-143.92	-128.63
Comprehensive Income	-1.93	-1.43	-1.2	-0.77	-0.74	-0.74
Shareholders' Equity	18.25	19.62	31.36	-19.86	-122.25	-107.54
Net Cash / Debt	5.58	0.95	21.94	-20.85	-38.75	-23.13
Net Cash / Debt Growth	-33.90%	-95.66%	-	-	-	-
Net Cash Per Share	0.09	0.02	0.48	-0.66	-1.38	-5.48
Working Capital	8.54	8.75	39.51	-8.46	-15.33	-11.7
Book Value Per Share	0.29	0.35	0.68	-0.63	-4.34	-25.49

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).